Isolation and characterization of monoclonal antibodies that inhibit hepatitis C virus NS3 protease

Journal of Virology

Volumn 74, Issue 14, 2000, Pages 6300-6308

  Ueno, Takamasa ^a,c   Misawa, Satoru ^a   Ohba, Yoichi ^a   Matsumoto, Mitsuhiro ^a   Mizunuma, Makiko ^a   Kasai, Nobuhiro ^b   Tsumoto, Kouhei ^b   Kumagai, Izumi ^b   Hayashi, Hideya ^a  

^a JAPAN ENERGY CORPORATION   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; PROTEINASE; VIRUS ENZYME; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME CONFORMATION; ENZYME INHIBITION; HEPATITIS C VIRUS; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; BINDING, COMPETITIVE; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; HEPACIVIRUS; KINETICS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN CONFORMATION; SURFACE PLASMON RESONANCE; VIRAL NONSTRUCTURAL PROTEINS;

EID: 0033937282     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.14.6300-6308.2000     Document Type: Article

References (41)

1. Barbato, G., D. O. Cicero, M. C. Nardi, C. Steinkuhler, R. Cortese, R. De Francesco, and R. Bazzo. 1999. The solution structure of the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein provides new insights into its activation and catalytic mechanism. J. Mol. Biol. 289:371-384.
2. Bartenschlager, R. 1997. Molecular targets in inhihition of hepatitis C virus replication. Antivir. Chem. Chemother. 8:281-301.
3. Bartenschlager, R., L. Ahlborn-Laake, J. Mous, and H. Jacobsen. 1994. Kinetic and structural analyses of hepatitis C virus polyprotein processing. J. Virol. 68:5045-5055.
4. Bartenschlager, R., L. Ahlborn-Laake, J. Mous, and H. Jacobsen. 1993 Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions. J. Virol. 67: 3835-3844.
5. Chen, M., M. Sallberg, A. Sonnerborg, L. Jin, A. Birkett, D. Peterson, O. Weiland, and D. R. Milich. 1998. Human and murine antibody recognition is focused on the ATPase/helicase, but not the protease domain of the hepatitis C virus nonstructural 3 protein. Hepatology 28:219-224.
6. Cicero, D. O., G. Barbato, U. Koch, P. Ingallinella, E. Bianchi, M. C. Nardi, C. Steinkuhler, R. Cortese, V. Matassa, R. De Francesco, A. Pessi, and R. Bazzo. 1999. Structural characterization of the interactions of optimized product inhibitors with the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein by NMR and modelling studies. J. Mol. Biol. 289: 385-396.
7. De Francesco, R., A. Urbani, M. C. Nardi, L. Tomei, C. Steinkuhler, and A. Tramontano. 1996. A zinc binding site in viral serine proteinases. Biochemistry 35:13282-13287.
8. Dimasi, N., F. Martin, C. Volpari, M. Brunetti, G. Biasiol, S. Altamura, R. Cortese, R. De Francesco, C. Steinkühler, and M. Sollazzo. 1997. Characterization of engineered hepatitis C virus NS3 protease inhibitors affinity selected from human pancreatic secretory trypsin inhibitor and minibody repertoires. J. Virol. 71:7461-7469.
9. Dimasi, N., A. Pasquo, F. Martin, S. Di Marco, C. Steinkuhler, R. Cortese, and M. Sollazzo. 1998. Engineering, characterization and phage display of hepatitis C virus NS3 protease and NS4A cofactor peptide as a single-chain protein. Protein Eng. 11:1257-1265.
10. Dougall, W. C., N. C. Peterson, and M. I. Greene. 1994. Antibody-structure-based design of pharmacological agents. Trends Biotechnol. 12:372-379.
11. Eckart, M. R., M. Selby, F. Masiarz, C. Lee, K. Berger, K. Crawford, C. Kuo, G. Kuo, M. Houghton, and Q. L. Choo. 1993. The hepatitis C virus encodes a serine protease involved in processing of the putative nonstructural proteins from the viral polyprotein precursor. Biochem. Biophys. Res. Commun. 192:399-406.
12. Failla, C., L. Tomei, and R. De Francesco. 1995. An amino-terminal domain of the hepatitis C virus NS3 protease is essential for interaction with NS4A. J. Virol. 69:1769-1777.
13. Failla, C., L. Tomei, and R. De Francesco. 1994. Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins. J. Virol. 68:3753-3760.
14. Fujinaga, M., L. T. J. Delbaere, G. D. Brayer, and M. N. G. James. 1985. Refined structure of alpha-lytic protease at 1.7 A resolution: analysis of hydrogen bonding and solvent structure. J. Mol. Biol. 184:479-502.
15. Goldberg, M. E. 1991. Investigating protein conformation, dynamics, and folding with monoclonal antibodies. Trends Biochem. Sci. 16:358-362.
16. Grakoui, A., D. W. McCourt, C. Wychowski, S. M. Feinstone, and C. M. Rice. 1993. Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase dependent polyprotein cleavage sites. J. Virol. 67:2832-2841.
17. Hibino, T., S. Misawa, M. Wakiyama, S. Maeda, K. Yazaki, I. Kumagai, T. Ooi, and K. Miura. 1994. High-level expression of porcine muscle adenylate kinase in Escherichia coli: effects of the copy number of the gene and the translational initiation signals. J. Biotechnol. 32:139-148.
18. Hijikata, M., H. Mizushima, T. Akagi, S. Mori, N. Kakiuchi, N. Kato, T. Tanaka, K. Kimura, and K. Shimotohno. 1993. Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J. Virol. 67:4665-4675.
19. Kakiuchi, N., Y. Komoda, K. Komoda, N. Takeshita, S. Okada, T. Tani, and K. Shimotohno. 1998. Non-peptide inhibitors of HCV serine proteinase. FEBS Lett. 421:217-220.
20. Kato, N., M. Hijikata, Y. Ootsuyama, M. Nakagawa, S. Ohkoshi, T. Sugimura, and K. Shimotohno. 1990. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A. non-B hepatitis. Proc. Natl. Acad. Sci. USA 87:9524-9528.
21. Kim, J. L., K. A. Morgenstern, C. Lin, T. Fox, M. D. Dwyer, J. A. Landro, S. P. Chambers, W. Markland, C. A. Lepre, E. T. O'Malley, S. L. Harbeson, C. M. Rice, M. A. Murcko, P. R. Caron, and J. A. Thomson. 1996. Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide. Cell 87:343-355.
22. Kumar, P. K., K. Machida, P. T. Urvil, N. Kakiuchi, D. Vishnuvardhan, K. Shimotohno, K. Taira, and S. Nishikawa. 1997. Isolation of RNA aptamers specific to the NS3 protein of hepatitis C virus from a pool of completely random RNA. Virology 237:270-282.
23. Kwong, A. D., J. L. Kim, G. Rao, D. Lipovsek, and S. A. Raybuck. 1998. Hepatitis C virus NS3/4A protease. Antivir. Res. 40:1-18.
24. Landro, J. A., S. A. Raybuck, Y. P. C. Luong, E. T. O'Malley, S. L. Harbeson, K. A. Morgenstern, G. Rao, and D. J. Livingston. 1997. Mechanistic role of an NS4A peptide cofactor with the truncated NS3 protease of hepatitis C virus: elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping. Biochemistry 36:9340-9348.
25. Laskowski, R. A., N. M. Luscombe, M. B. Swindells, and J. M. Thornton. 1996. Protein clefts in molecular recognition and function. Protein Sci. 5: 2438-2452.
26. Lin, C., B. M. Prégai, A. Grakoui, J. Xu, and C. M. Rice. 1994. Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics. J. Virol. 68:8147-8157.
27. Llinas-Brunet, M., M. Bailey, G. Fazal, S. Goulet, T. Halmos, S. Laplante, R. Maurice, M. Poirier, M. A. Poupart, D. Thibeault, D. Wernic, and D. Lamarre. 1998. Peptide-based inhibitors of the hepatitis C virus serine protease. Bioorg. Med. Chem. Lett. 8:1713-1718.
28. Love, R. A., H. E. Parge, J. A. Wickersham, Z. Hostomsky, N. Habuka, E. W. Moomaw, T. Adachi, and Z. Hostomska. 1996. The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site. Cell 87:331-342.
29. Love, R. A., H. E. Parge, J. A. Wickersham, Z. Hostomsky, N. Habuka, E. W. Moomaw, T. Adachi, S. Margosiak, E. Dagostino, and Z. Hostomska. 1998. The conformation of hepatitis C virus NS3 proteinase with and without NS4A: a structural basis for the activation of the enzyme by its cofactor. Clin. Diagn. Virol. 10:151-156.
30. Lu, Z., K. S. Murray, V. V. Cleave, E. R. LaVallie, M. L. Stahl, and J. M. McCoy. 1995. Expression of thioredoxin random peptide libraries on the Escherichia coli cell surface as functional fusions to flagellin: a system designed for exploring protein-protein interactions. Bio/Technology 13:366-372.
31. Martin, F., C. Volpari, C. Steinkuhler, N. Dimasi, M. Brunetti, G. Biasiol, S. Altamura, R. Cortese, R. De Francesco, and M. Sollazzo. 1997. Affinity selection of a camelized V(H) domain antibody inhibitor of hepatitis C virus NS3 protease. Protein Eng. 10:607-614.
32. Miltenyi, S., W. Muller, W. Weichel, and A. Radbruch. 1990. High gradient magnetic cell separation with MACS. Cytometry 11:231-238.
33. Novotny, J. 1991. Protein antigenicity: a thermodynamic approach. Mol. Immunol. 28:201-207.
34. Sheriff, S., and K. L. Constantine. 1996. Redefining the minimal antigen-binding fragment. Nat. Struct. Biol. 3:733-736.
35. Shimizu, Y., K. Yamaji, Y. Masuho, T. Yokota, H. Inoue, K. Sudo, S. Satoh, and K. Shimotohno. 1996. Identification of the sequence on NS4A required for enhanced cleavage of the NS5A/5B site by hepatitis C virus NS3 protease. J. Virol. 70:127-132.
36. Sollazzu, M. 1995. From protein engineering to drug design: imitating how antibodies do it. Immunologist 3:5-11.
37. Steinkuhler, C., G. Biasiol, M. Brunetti, A. Urbani, U. Koch, R. Cortese, A. Pessi, and R, De Francesco. 1998. Product inhibition of the hepatitis C virus NS3 protease. Biochemistry 37:8899-8905.
38. Steinkuhler, C., A. Urbani, L. Tomei, G. Biasiol, M. Sardana, E. Bianchi, A. Pessi, and R. De Francesco. 1996. Activity of purified hepatitis C virus protease NS3 on peptide substrates. J. Virol. 70:6694-6700.
39. Tanji, Y., M. Hijikata, S. Satoh, T. Kaneko, and K. Shimotohno. 1995. Hepatitis C virus-encoded nonstructural protein NS4A has versatile functions in viral protein processing. J. Virol. 69:1575-1581.
40. Tomei, L., C. Failla, E. Santolini, R. De Francesco, and N. La Monica. 1993. NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J Virol. 67:4017-4026.
41. Yan, Y., Y. Li, S. Munshi, V. Sardana, J. L. Cole, M. Sardana, C. Steinkuhler, L. Tomei, R. De Francesco, L. C. Kuo, and Z. Chen. 1998 Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: a 2.2 A resolution structure in a hexagonal crystal form. Protein Sci. 7:837-847.